ArticleInternational journal of molecular sciences2021

ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.

Jeon-Soo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.